Trial Profile
Effectiveness of ivabradine plus beta-blockers compared to up-titration of beta-blockers in patients with stable angina pectoris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2012
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Beta-adrenergic receptor antagonists
- Indications Angina pectoris
- Focus Therapeutic Use
- 14 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.